MedPath

Acceptance and Commitment Therapy in the Treatment of Obesity: Pilot.

Not Applicable
Withdrawn
Conditions
Obesity, Acceptance and Commitment Therapy, Weight Management Service
Interventions
Behavioral: Acceptance and commitment therapy
Behavioral: Treatment as usual (dietetic intervention)
Registration Number
NCT03075345
Lead Sponsor
University of Sheffield
Brief Summary

Obesity is an 'epidemic' within the UK. Individuals living with obseity are at risk of developing cancer, heart problems and dieing. Furthermore, obesity impacts on psychological wellbeing via lowered self-efficacy, self-esteem, body image and overall quality of life (QoL). A pilot randomised controlled trial (RCT) is proposed to investigate the additional benefit of a psychological intervention alongside treatment as usual (TAU) in a weight management service. Patients routinely attending an outpatient clinic will be randomised into TAU with or without additional acceptance and commitment Therapy (ACT) group based-input and their outcomes monitored over time.

Detailed Description

Overweight and obesity is reported as an 'epidemic' problem within the UK as well as the world. Individuals living with this may be at higher risk of developing co-morbidities, such as cancers, heart problems or diabetes, and higher mortality rates are reported in this group. Furthermore, overweight and obesity can also impact on a person's psychological wellbeing, such as their self-efficacy, self-esteem and body image as well as have a negative effect on their overall quality of life (QoL). Therefore, a pilot randomised controlled trial (RCT) is proposed to investigate the additional benefit of a psychological intervention alongside treatment as usual (TAU) in a weight management service. Patients routinely attending an outpatient clinic will be randomised into TAU with or without additional Acceptance and Commitment Therapy (ACT) group based-input.

Recruitment & Eligibility

Status
WITHDRAWN
Sex
All
Target Recruitment
Not specified
Inclusion Criteria
  • Individuals will be willing and able to give informed consent for participation in the study;
  • Male or Female, aged 18 years or above.
  • Individuals will have a Body Mass Index (BMI) of over 40 (or over 35 if they are from a black or other minority ethic (BME) group or have a co-existing physical health problem);
  • Individuals will be on a waiting list for a weight loss management programme in the UK;
  • Individuals will have English as a written language.
Exclusion Criteria
  • Individuals who are currently pregnant or breastfeeding;
  • Individuals with current drug or alcohol abuse, such that would prevent them from engaging in a weight management programme;
  • Individuals who are acutely mentally unwell, such that would prevent them from engaging in a weight management programme;
  • Individuals who at time of referral are at significant risk to themselves of others, such that would prevent them from engaging in a weight management programme;
  • Individuals who are acutely physically unwell and/or hospitalised, such that would prevent them from engaging in a weight management programme;
  • Individuals who have a learning disability or cognitive impairment, such that would prevent them from engaging in a weight management programme.
  • Currently in receipt of psychiatric services.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Treatment as usual plus acceptance and commitment therapyTreatment as usual (dietetic intervention)6 session weight management programme (over 12 weeks) plus a 4 session acceptance and commitment therapy (ACT) programme. The ACT part will commence straight after the conclusion of the weight management programme.
Treatment as usual (weight management intervention)Treatment as usual (dietetic intervention)6 session weight management programme (over 12 weeks).
Treatment as usual plus acceptance and commitment therapyAcceptance and commitment therapy6 session weight management programme (over 12 weeks) plus a 4 session acceptance and commitment therapy (ACT) programme. The ACT part will commence straight after the conclusion of the weight management programme.
Primary Outcome Measures
NameTimeMethod
Hospital Anxiety and Depression Scale (HADS)7 days

A measure of psychological distress in relation to anxiety and depression symptoms. There is a total of 14 items (7 items relate to anxiety; 7 items relate to depression) with answers scored on a Likert scale of 0-3 (scores from 0-42; higher scores indicating worse symptoms).

Secondary Outcome Measures
NameTimeMethod
Medical Outcomes Study 36-Item Short-Form Health Survey (SF-36)24 hours

The SF-36 is a generic measure of health related quality of life. There is a total of 36 questions which can be grouped into 3 levels: i) 36 individual items; ii) 8 subscales; iii) 2 summary measures.

Action and Acceptance Questionnaire - II (AAQ-II)24 hours

The AAQ-II is a measure of experiential avoidance (i.e., attempts to alter difficult internal experiences which often leads to increased distress) and psychological inflexibility. Patients are asked to rate their experiences on a 7-point Likert scale (from '1: never true' to '7: always true').

Eating Self-Efficacy Scale (ESES)24 hours

It measures self-efficacy. It contains 25-items measuring the person's confidence in ability to manage overeating in various situations (Likert scale 1-7 used).

Trial Locations

Locations (1)

University of Sheffield

🇬🇧

Sheffield, United Kingdom

© Copyright 2025. All Rights Reserved by MedPath